SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?

Seeking Alpha05:12

JMP Securities Maintains CRISPR Therapeutics(CRSP.US) With Buy Rating, Maintains Target Price $86

Futu NewsDec 21 02:31 · Ratings

CRISPR Therapeutics: Promising Developments and Positive Outlook Amid Advancements in Gene-Editing

TipRanksDec 21 01:58

1 Big New Green Flag for CRISPR Therapeutics' Stock

Yahoo FinanceDec 20 22:30

Clear Street Initiates CRISPR Therapeutics(CRSP.US) With Hold Rating, Announces Target Price $45

Futu NewsDec 19 19:31 · Ratings

Piper Sandler Maintains CRISPR Therapeutics(CRSP.US) With Buy Rating, Maintains Target Price $105

Futu NewsDec 16 20:34 · Ratings